<DOC>
	<DOCNO>NCT00817895</DOCNO>
	<brief_summary>Hepatectomy still important treatment HCC.High recurrence rate mostly influence 's prognosis , especially patient tumor &gt; 5cm , multiple tumor accept R0 resection.Our retrospective study show sustain release 5-FU implanted liver incisal margin tumor resect could reduce recurrence rate HCC liver resection.According , proceed RCT prospectively observe effect sustain release 5-FU , also want know whether combine sustain release cisplatin get good effect prevent tumor recurrence , especially short time liver resection .</brief_summary>
	<brief_title>Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence</brief_title>
	<detailed_description>150 HCC patient tumor &gt; 5cm , multiple tumor accept R0 resection randomize divide 3 group . Group A ( 50 case ) implant 600mg sustain release 5-FU liver incisal margin tumor resect . Group B ( 50 case ) implant 600mg sustain release 5-FU 60mg sustain release cisplatin . Group C ( 50 case ) control one implant chemotherapeutic drug . All patient accept TACE 30 day liver resection . We follow patient dead miss connect . Related adverse reaction record . Total survival time ( TST ) disease free survival time ( DFST ) calculate . At end study compare difference adverse reaction , complication , TST DFST 3 group . According result estimate drug ' antitumor effect safety .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>1. tumor &gt; 5cm ; 2. multiple tumor locate one liver lobe ; 3. margin tumor clear ; 4. cut edge tumor &lt; 1cm ; 5. portal vein branch invasion ; 6. without extraliver metastasis ; 7. patient 's liver function condition able accept hepatectomy . 1. single tumor &lt; =5cm ; 2. multiple tumor locate one liver lobe ; 3. margin tumor clear ; 4. cut edge tumor &gt; =1cm ; 5. portal vein stem invasion 6. extraliver metastasis ; 7. patient 's liver function condition accept hepatectomy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>liver resection</keyword>
	<keyword>intraoperative chemotherapy</keyword>
</DOC>